Medeon

SEQ_NO	2	Date of announcement	2025/09/24	Time of announcement	16:46:15
Subject	Medeon, on behalf of its subsidiary PMC, announces Cash Capital Increase: Waiver by All Directors and Subscription by Specific Parties
Date of events	2025/09/24	To which item it meets	paragraph 45
Statement	1.Date of occurrence of the event:2025/09/24 2.Reason for the forfeiture of subscription rights by the directors nd supervisors: PMC has entered the commercialization and stage. To strengthen its global presence and accelerate strategic collaborations, the Company intends to bring in strategic investors with international resources. In light of the current global capital market uncertainties and in alignment with the Medeon’s overall financial planning, the Board of Directors has resolved to forgo participation in this cash capital increase. 3.Name of director/supervisor, number of shares forfeited, and the percentage out of total subscription: Director?GMedeon Biodesign, Inc. Number of shares forfeited: 2,856,017 shares The percentage out of total subscription: 100% 4.Name(s) of the specific person(s) and no.of shares subscribed: Pursuant to the authorization of PMC’s Board of Directors, the Chairman of PMC is authorized to negotiate with specific parties for the subscription 5.Any other matters that need to be specified:None.